Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
5
×
crispr
5
×
life sciences
national
5
×
national blog main
national top stories
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
boston top stories
deals
eli lilly
europe blog main
fda
gene therapy
gilead sciences
glaxosmithkline
multiple myeloma
novartis
What
bio
roundup
companies
crispr
month
new
therapeutics
access
acquisitions
advanced
announced
approval
biogen’s
biopharma
biopharmaceutical
black
capacity
car
cell
ceo
collabs
congress
congressional
consolidation
continue
convo
covid
daniel
deal
debut
diamond
diamond’s
drug
earlier
executives
failures
falcon
feud
focus
gene
Language
unset
Current search:
crispr
×
national
×
" clinical trials "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More